Ocugen Inc
(MEX:OCGN)
MXN
20.68
(0%)
Market Cap: 7.22 Bil
Enterprise Value: 7.25 Bil
PE Ratio: 0
PB Ratio: 73.53
GF Score: 35/100 Ocugen Inc at Cantor Fitzgerald Global Healthcare Conference Transcript
Sep 26, 2023 / 05:00PM GMT
Release Date Price:
MXN7.2
Jennifer Kim
Cantor Fitzgerald - Moderator
Okay. Good afternoon, everyone. Welcome to the Cantor Global Healthcare Conference. We're going to start our next panel. I'm Jennifer Kim, a research analyst here at Cantor. I'm looking forward to hosting Eyenovia, Ocugen, and Tarsier Pharma for this ocular-themed panel. So thank you to all three of you for coming.
Michael Rowe
Eyenovia, Inc. - CEO
Thank you.
Shankar Masunuri
Ocugen, Inc. - Co-Founder, Chairman & CEO
Thank you for having us.
Jennifer Kim
Cantor Fitzgerald - Moderator
Maybe we could start off. Maybe we could go in a straight line. Could you introduce yourselves and give a brief overview of your company? So I guess, Shankar, we can start with you.
Shankar Masunuri
Ocugen, Inc. - Co-Founder, Chairman & CEO
Shankar Masunuri, Chairman and CEO, Co-Founder, Ocugen. We're a patient-centric biotech company focused on gene and cell therapies targeting unmet
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot